Belite Bio Ownership | Who Owns Belite Bio?

Belite Bio Ownership Summary

Belite Bio is owned by 3.07% institutional investors, 46.78% insiders, and 50.14% retail investors. Ra capital management is the largest institutional shareholder, holding 2.69% of BLTE shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 0.97% of its assets in Belite Bio shares.

BLTE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Belite Bio	3.07%	46.78%	50.14%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	875.00K	2.69%	$64.75M
Rtw investments, lp	312.50K	0.96%	$23.13M
Vestal point capital, lp	312.50K	0.96%	$23.13M
Eventide asset management	195.31K	0.60%	$14.45M
Marshall wace, llp	187.50K	0.58%	$13.88M
Ubs group	128.75K	0.39%	$20.60M
Western standard	60.03K	0.18%	$9.60M
Perceptive advisors	49.79K	0.15%	$3.68M
Goldman sachs group	44.60K	0.13%	$7.13M
Soleus capital management	40.35K	0.12%	$6.46M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Western standard	60.03K	4.43%	$9.60M
Vestal point capital, lp	312.50K	1.04%	$23.13M
Ra capital management	875.00K	0.80%	$64.75M
Rtw investments, lp	312.50K	0.28%	$23.13M
Soleus capital management	40.35K	0.24%	$6.46M
Eventide asset management	195.31K	0.24%	$14.45M
High net worth advisory group	3.50K	0.13%	$559.86K
Caitong asset management	283.00	0.12%	$45.27K
Yeomans consulting group	2.40K	0.11%	$383.74K
Perceptive advisors	49.79K	0.11%	$3.68M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	875.00K	0.80%	875.00K
Rtw investments, lp	312.50K	0.28%	312.50K
Vestal point capital, lp	312.50K	1.04%	312.50K
Eventide asset management	195.31K	0.24%	195.31K
Marshall wace, llp	187.50K	0.01%	178.01K

Top Sellers

Holder	Shares	% Assets	Change
Soleus capital management	40.35K	0.24%	-169.65K
Armistice capital	-	-	-167.93K
Alyeska investment group	-	-	-83.62K
Jpmorgan chase	3.00	-	-9.81K
Bnp paribas arbitrage, snc	2.45K	0.00%	-9.10K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	875.00K	0.80%	875.00K	$64.75M
Rtw investments, lp	312.50K	0.28%	312.50K	$23.13M
Vestal point capital, lp	312.50K	1.04%	312.50K	$23.13M
Eventide asset management	195.31K	0.24%	195.31K	$14.45M
Western standard	60.03K	4.43%	60.03K	$9.60M

Sold Out

Holder	Change
Pnc financial services group	-8.00
Quantbot technologies lp	-11.00
Tower research capital llc (trc)	-14.00
Advisors preferred	-798.00
Virtus etf advisers	-1.12K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	37	8.82%	1,020,646	-55.40%	3	6.23%	27	-3.57%	8	60.00%
Sep 30, 2025	33	106.25%	2,288,468	3161.04%	7	15139.46%	28	180.00%	4	-20.00%
Jun 30, 2025	18	-	78,139	-47.79%	-	105.93%	12	-	5	-
Mar 31, 2025	18	-14.29%	149,657	-47.01%	-	56.18%	12	-14.29%	5	-
Dec 31, 2024	21	40.00%	282,406	258.84%	-	1398.99%	14	27.27%	5	150.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Eventide Healthcare & Life Sciences I	383.09K	0.97%	187.78K
MEDICAL BioHealth EUR Acc	130.19K	0.33%	-13.47K
HBM Healthcare Investments AG Ord	90.00K	0.26%	90.00K
Alger Small Cap Focus I	51.65K	0.13%	-5.58K
Alger Small Cap Focus Composite	51.65K	0.13%	-5.58K
apo Medical Opportunities R	23.16K	0.06%	-5.50K
RIM Global Bioscience EUR	16.60K	0.04%	7.00K
SPDR® Portfolio Emerging Markets ETF	10.93K	0.03%	-
State Street® SPDR® Portfolio EM ETF	12.46K	0.03%	-
MS INVF Global Endurance Z USD Acc	9.21K	0.02%	9.21K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 15, 2026	MATA NATHAN L.	Chief Scientific Officer	Sell	$11.50K
Apr 15, 2026	MATA NATHAN L.	Chief Scientific Officer	Sell	$1.37K
Apr 15, 2026	MATA NATHAN L.	Chief Scientific Officer	Sell	$64.18K
Apr 15, 2026	MATA NATHAN L.	Chief Scientific Officer	Sell	$90.56K
Apr 15, 2026	MATA NATHAN L.	Chief Scientific Officer	Sell	$684.76

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	14
2026 Q1	-	-

BLTE Ownership FAQ

Who Owns Belite Bio?

Belite Bio shareholders are primarily institutional investors at 3.07%, followed by 46.78% insiders and 50.15% retail investors. The average institutional ownership in Belite Bio's industry, Biotech Stocks , is 382.13%, which Belite Bio falls below.

Who owns the most shares of Belite Bio?

Belite Bio’s largest shareholders are Ra capital management (875K shares, 2.69%), Rtw investments, lp (312.5K shares, 0.96%), and Vestal point capital, lp (312.5K shares, 0.96%). Together, they hold 4.60% of Belite Bio’s total shares outstanding.

Does Blackrock own Belite Bio?

BlackRock is not among the top 10 institutional shareholders of Belite Bio.

Who is Belite Bio’s biggest shareholder by percentage of total assets invested?

Western standard is Belite Bio’s biggest shareholder by percentage of total assets invested, with 4.43% of its assets in 60.03K Belite Bio shares, valued at 9.6M$.

Who is the top mutual fund holder of Belite Bio shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Belite Bio shares, with 0.97% of its total shares outstanding invested in 383.09K Belite Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools